Pathway to Protection: Expanding Availability of COVID-19 Vaccines

Pathway to Protection: Expanding Availability of COVID-19 Vaccines

E
Energy and Commerce Committee
13 Video Views·Dec 26, 2022

The Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce will hold a hearing on Tuesday, February 23, 2021, at 10:30 a.m. via Cisco WebEx. The hearing is entitled, "Pathway to Protection: Expanding Availability of COVID-19 Vaccines."

Witnesses:

John Young
Group President, Chief Business Officer
Pfizer

Dr. Stephen Hoge
President
Moderna

Dr. Richard Nettles
Vice President of Medical Affairs, Janssen Pharmaceutical Companies
Johnson & Johnson

Dr. Ruud Dobber
Exectuive Vice President and President, BioPharmaceuticals Business Unit
AstraZeneca

John Trizzino
Executive Vice President, Chief Commercial Officer, and Chief Business Officer
Novavax, Inc.

https://energycommerce.house.gov/committee-activity/hearings/hearing-on-pathway-to-protection-expanding-availability-of-covid-19